Jim Simons Co Diagnostics, Inc. Transaction History
Renaissance Technologies LLC
- $63.1 Billion
- Q3 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 567,722 shares of CODX stock, worth $471,209. This represents 0.0% of its overall portfolio holdings.
Number of Shares
567,722
Previous 587,000
3.28%
Holding current value
$471,209
Previous $733,000
3.27%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CODX
# of Institutions
43Shares Held
4.28MCall Options Held
48.2KPut Options Held
53.3K-
Vanguard Group Inc Valley Forge, PA1.78MShares$1.48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$416,6800.0% of portfolio
-
Geode Capital Management, LLC Boston, MA321KShares$266,6580.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX273KShares$226,5070.01% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA188KShares$155,6820.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $28M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...